Sahajian F, Berger-Vergiat A, Pot E
Service medico-psychologique régional à la prison de Lyon-Corbas, centre hospitalier Le Vinatier, 95, boulevard Pinel, 69677 Bron, France; CSAPA antenne toxicomanies à la prison de Lyon-Corbas, centre hospitalier Le Vinatier, 95, boulevard Pinel, 69677 Bron, France; Laboratoire d'épidémiologie et de santé publique, faculté de médecine Domaine-Rockefeller, 8, avenue Rockefeller, 69008 Lyon, France.
Service medico-psychologique régional à la prison de Lyon-Corbas, centre hospitalier Le Vinatier, 95, boulevard Pinel, 69677 Bron, France; CSAPA, groupement hospitalier Édouard-Herriot, hospices civils de Lyon, place d'Arsonval, 69003 Lyon, France.
Rev Epidemiol Sante Publique. 2017 Sep;65(5):361-367. doi: 10.1016/j.respe.2017.05.007. Epub 2017 Sep 6.
In prison, in 2012, according to various sources, from 4 to 56% of the European inmate population used psychoactive substances (PAS). The aim of our study was to describe PAS consumption during incarceration in the prison of Lyon-Corbas, France.
A transversal descriptive study was conducted between September 23rd and September 27th 2013 among all inmates of this prison. We used an anonymous self-administered questionnaire, distributed at lunchtime and collected, the same day, at dinnertime, by the mental health service personnel.
Among 785 inmates present at the time of the study in the prison of Lyon-Corbas, 710 were included and the response rate was 64.4% (95% CI [60.8-67.8]). Among 457 responding inmates, 16.4% (95% CI [13.2-20.0]) reported no PAS consumption. Among 382 consumers, 74.4% (95% CI [69.8-78.5]) used tobacco, 36.8% (95% CI [32.2-41.8]) cannabis, 30.4% (95% CI [25.9-35.1]) alcohol, 7.7% (95% CI [5.2-10.6]) heroin and 10.3% (95% CI [7.5-13.6]) cocaine. Furthermore, 15% of consumers had started PAS consumption during their incarceration. Among consumers of at least one PAS other than tobacco, cannabis and alcohol, the way of consumption was sniff for 60.0% (95% CI [48.5-70.2]) and injection for 31.0% (95% CI [21.6-42.1]). Use of several PAS at the same time and sharing sniffing and/or injection paraphernalia were other risky behaviors observed; 12% (95% CI [5.8-20.4]) of drug injectors declared using chlorine to sterilize their injection paraphernalia.
Our study provides worrying data about PAS consumption in prison. The measures of prohibition do not prevent this consumption. There is even an initiation of consumption of PAS for 15% of the first-time incarcerated inmates. This finding should encourage public authorities to facilitate access of inmates to the care structures in prisons, to improve drug use prevention and care programs and to develop activities (sports, cultural, educational and vocational).
2012年，据不同来源的数据显示，在欧洲监狱中，4%至56%的囚犯使用过精神活性物质（PAS）。我们研究的目的是描述法国里昂 - 科尔巴斯监狱中囚犯在监禁期间对精神活性物质的使用情况。
2013年9月23日至9月27日，对该监狱的所有囚犯进行了一项横断面描述性研究。我们使用了一份匿名的自填问卷，在午餐时间发放，并于当天晚餐时间由心理健康服务人员收集。
在里昂 - 科尔巴斯监狱研究期间在场的785名囚犯中，有710人被纳入研究，应答率为64.4%（95%置信区间[60.8 - 67.8]）。在457名应答囚犯中，16.4%（95%置信区间[13.2 - 20.0]）报告未使用过精神活性物质。在382名使用者中，74.4%（95%置信区间[69.8 - 78.5]）使用烟草，36.8%（95%置信区间[32.2 - 41.8]）使用大麻，3
